Investigation of Aspergillus galactomannan levels in antimicrobial agents;Anti̇mi̇krobi̇yal i̇laçlarda Aspergillus galaktomannan düzeyleri̇ni̇n araştirilmasi

Mikrobiyoloji Bulteni

Volumn 41, Issue 4, 2007, Pages 565-570

  Yücesoy, Mine ^a   Ergon, M Cem ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Antimicrobial agents; Aspergillus; Enzyme immunoassay; Galactomannan

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; FUNGUS ANTIGEN; GALACTOMANNAN; MANNAN; PENICILLANIC ACID; PIPERACILLIN; PIPERACILLIN TAZOBACTAM COMBINATION PRODUCT; PIPERACILLIN-TAZOBACTAM COMBINATION PRODUCT;

ARTICLE; ASPERGILLOSIS; ASPERGILLUS; CHEMISTRY; CROSS REACTION; DRUG CONTAMINATION; ENZYME IMMUNOASSAY; HUMAN; IMMUNOLOGY; LABORATORY DIAGNOSIS;

AMPICILLIN; ANTI-BACTERIAL AGENTS; ANTIGENS, FUNGAL; ASPERGILLOSIS; ASPERGILLUS; CROSS REACTIONS; DRUG CONTAMINATION; FALSE POSITIVE REACTIONS; HUMANS; IMMUNOENZYME TECHNIQUES; MANNANS; PENICILLANIC ACID; PIPERACILLIN;

EID: 48849092528     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Vandewoude KH, Vogelaers D, Blot SI. Aspergillosis in the ICU - The new 21st century problem? Med Mycol 2006; 44 (suppl): S71-6.
2. Mehrad B, Paciocco G, Martinez FJ, Ojo TC, Iannettoni MD, Lynch JP 3rd. Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature. Chest 2001; 119: 169-75.
3. Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C, et al. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care 2005; 9: R191-9.
4. Albelda SM, Talbot GH, Gerson SL, Miller WT, Cassileth PA. Role of fiberoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia. Am J Med 1984; 76: 1027-34.
5. Kahn FW, Jones JM, England DM. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis. Am J Clin Pathol 1986; 86: 518-23.
6. Levy H, Horak DA, Tegtmeier BR, Yokota SB, Forman SJ. The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Respir Med 1992; 86: 243-8.
7. Bretagne S, Marmorat-Khuong A, Kuentz M, Latge JP, Bart-Delabesse E, Cordonnier C. Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients. J Infect 1997; 35: 7-15.
8. Maertens J, Verhaegen J, Demuynck H, et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis. J Clin Microbiol 1999; 37: 3223-8.
9. Verweij PE, Rijs AJ, De Pauw BE, Horrevorts AM, Hoogkamp-Korstanje JA, Meis JF. Clinical evaluation and reproducibility of the Pastorex Aspergillus antigen latex agglutination test for diagnosing invasive aspergillosis. J Clin Pathol 1995; 48: 474-6.
10. Verweij PE, Erjavec Z, Sluiters W, et al. Detection of antigen in sera of patients with invasive aspergillosis: intra and interlaboratory reproducibility. J Clin Microbiol 1998; 36: 1612-6.
11. th ed. Churchill Livingstone, Pennsylvania.
12. Walsh TJ, Shoham S, Petraitiene R, et al. Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. J Clin Microbiol 2004; 42: 4744-8.
13. Pinel C, Fricker-Hidalgo H, Lebeau B, et al. Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the Platelia test for diagnosing invasive aspergillosis. J Clin Microbiol 2003; 41: 2184-6.
14. Sulahian A, Touratier S, Ribaud P. False positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med 2003; 349: 2366-7.
15. Viscoli C, Machetti M, Cappellano P, et al. False-positive galactomannan Platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clin Infect Dis 2004; 38: 913-6.
16. Adam O, Auperin A, Wilquin F, Bourhis JH, Gachot B, Chachaty E. Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin Infect Dis 2004; 38: 917-20.
17. Tanriover MD, Metan G, Altun B, Hasçelik G, Uzun O. False positivity for Aspergillus antigenemia related to the administration of piperacillin/tazobactam. Eur J Intern Med 2005; 16: 489-91.
18. Mennink-Kersten MA, Klont RR, Warris A, Op den Camp HJ, Verweij PE. Bifidobacterium lipoteichoic acid and false ELISA reactivity in Aspergillus antigen detection. Lancet 2004; 363: 325-7.
19. Ansorg R, van den Boom R, Rath PM. Detection of Aspergillus galactomannan antigen in foods and antibiotics. Mycoses 1997; 40: 353-7.
20. Swanink CM, Meis JF, Rijs AJ, Donnelly JP, Verweij PE. Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 1997; 35: 257-60.
21. th ed. Churchill Livingstone, Pennsylvania.
22. Bart-Delabesse E, Basile M, Al Jijakli A, et al. Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments. J Clin Microbiol 2005; 43: 5214-20.
23. Mattei D, Rapezzi D, Mordini N, et al. False-positive Aspergillus galactomannan enzyme-linked immunosorbent assay results in vivo during amoxicillin-clavulanic acid treatment. J Clin Microbiol 2004; 42: 5362-3.
24. Machetti M, Furfaro E, Viscoli C. Galactomannan in piperacillin- tazobactam: how much and to what extent? Antimicrob Agents Chemother 2005; 49: 3984-5.
25. Penack O, Schwartz S, Thiel E, Blau IW. Lack of evidence that false-positive Aspergillus galactomannan antigen test results are due to treatment with piperacillin-tazobactam. Clin Infect Dis 2004; 39: 1401-2.
26. Singh N, Obman A, Husain S, Aspinall S, Mietzner S, Stout JE. Reactivity of Platelia Aspergillus galactomannan antigen with piperacillin- tazobactam: Clinical implications based on achievable concentrations in serum. Antimicrob Agents Chemother 2004; 48: 1989-92.